ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,939Medicare Part D Prescriptions Filled, Including Refills

Rank: 142 out of 2715

$571K Total Retail Price of All Prescriptions

Rank: 321 out of 2715

686 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Michigan
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 686 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 481 466 114 1 2
LISINOPRIL 465 446 117 2 3
LEVOTHYROXINE SODIUM 450 415 114 3 4
AMLODIPINE BESYLATE 341 329 88 4 6
OMEPRAZOLE 306 301* 98 5 5
HYDROCODONE-ACETAMINOPHEN 295 248 66 S3 6 1
PRAVASTATIN SODIUM 274 262 79 7 16
METOPROLOL TARTRATE 252 247* 57 8 10
METFORMIN HCL 243 219 55 9 7
WARFARIN SODIUM 209 204* 54 10 18
FUROSEMIDE 186 181* 61 11 8
LOVASTATIN 180 165 44 12 32
ATORVASTATIN CALCIUM 174 158 51 13 9
SYNTHROID 169 164* 46 14 40
PREDNISONE 164 151 103 15 35
ZOLPIDEM TARTRATE 162 148 47 16 27
METHYLPREDNISOLONE 154 136 132 17 95
ALPRAZOLAM 152 136 53 B 18 11
CITALOPRAM HBR 133 128* 35 19 22
LOSARTAN POTASSIUM 128 113 30 20 17
CLOPIDOGREL 125 120* 30 21 21
PANTOPRAZOLE SODIUM 122 102 32 22 47
SERTRALINE HCL 120 115* 30 23 23
HYDROCHLOROTHIAZIDE 118 113* 34 24 12
DONEPEZIL HCL 113 113 20 25 33
LORAZEPAM 109 109 19 B 26 30
CARVEDILOL 109 104* 24 26 25
METOPROLOL SUCCINATE 106 101* 27 28 20
TAMSULOSIN HCL 102 97* 29 29 26
GLYBURIDE 94 89* 27 R 30 110
CIPROFLOXACIN HCL 92 87* 65 31 63
BISOPROLOL-HYDROCHLOROTHIAZIDE 88 88 21 32 130
ALLOPURINOL 88 83* 19 32 34
LOSARTAN-HYDROCHLOROTHIAZIDE 83 78* 19 34 58
FINASTERIDE 82 82 19 35 96
AMOXICILLIN 80 75* 68 36 100
AZITHROMYCIN 77 66 62 37 42
MONTELUKAST SODIUM 73 68* 11 38 64
TRAMADOL HCL 68 57 28 39 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 63* 20 39 24
DILTIAZEM 24HR ER 68 68 19 39 132
AMLODIPINE BESYLATE-BENAZEPRIL 67 62* 16 42 89
INDAPAMIDE 66 61* 16 43 242
ATENOLOL 66 61* 17 43 13
ISOSORBIDE MONONITRATE ER 65 60* 14 45 43
MECLIZINE HCL 62 57* 37 46 155
NAPROXEN 61 56* 15 47 77
TEMAZEPAM 59 <11 <11 B 48 127
IBUPROFEN 59 54* 21 48 39
POTASSIUM CHLORIDE 57 57 17 50 19
MELOXICAM 54 49* 13 51 36
GABAPENTIN 54 <11 <11 51 14
ACETAMINOPHEN-CODEINE 53 48* 19 S3 53 69
JANUVIA 51 51 11 54 88
TERAZOSIN HCL 50 45* 14 55 136
ALENDRONATE SODIUM 50 45* 14 55 38
DOXYCYCLINE HYCLATE 50 45* 43 55 162
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.